Abstract
Datamonitor' s Generics: Global Industry Guide is an essential resource for
top-level data and analysis covering the generics industry. It includes
detailed data on market size and segmentation, textual analysis of the key
trends and competitive landscape, and profiles of the leading companies. This
incisive report provides expert analysis on a global, regional and country
basis.
Scope of the Report
* Contains an executive summary and data on
value, volume and segmentation
* Provides textual analysis of the
industry' s prospects, competitive landscape and profiles of the leading
companies
* Incorporates in-depth five forces competitive environment analysis and
scorecards
* Covers the Global, European and Asia-Pacific markets as
well as individual chapters on 5 major markets (France, Germany, Japan, the UK
and the US).
* Includes a five-year forecast of the industry
Highlights
The global generics market grew by 12.3% in 2007 to reach a value of $108
billion.
In 2012, the market is forecast to have a value of $178 billion, an increase
of 64.7% since 2007.
The ethical generic segment dominates the market with 76.1% share.
The Americas generate 40.1% of the global genericas market' s value
Why you should buy this report
* Spot future trends and
developments
* Inform your business decisions
* Add weight
to presentations and marketing materials
* Save time carrying out
entry-level research
Market Definition
The value of the generics market consists of all sales of generics drugs at
ex-manufacturers prices. The market does not include animal healthcare
products. Datamonitor defines a generic as a product, which is an officially
approved copy of an original product whose patent has expired, marketed either
as a brand or using the generic name. This definition excludes multi-source
copy products that make up much of markets such as India, Spain and Italy. All
currency conversions have been calculated at constant 2007 average exchange
rates.
For the purpose of this report the Americas comprises Brazil, Canada, Mexico
and the US.
Europe comprises Belgium, the Czech Republic, Denmark, France, Germany,
Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the
UK.
Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea
and Taiwan.
The global figure comprises the Americas, Asia-Pacific and Europe.
Table of Contents
Table of Contents
CHAPTER 1 Introduction 20
1.1 What is this report
about? 20
1.2 Who is the target reader? 20
1.3 How to use this report
20
1.4 Definitions 21
CHAPTER 2 Global Generics 22
2.1 Market
Overview 22
2.2 Market Value 22
2.3 Market Segmentation I 22
2.4
Market Segmentation II 22
2.5 Five Forces Analysis 22
2.6 Market
Forecasts 22
CHAPTER 3 Generics in Asia-Pacific 22
3.1 Market Overview
22
3.2 Market Value 22
3.3 Market Segmentation I 22
3.4 Market
Segmentation II 22
3.5 Five Forces Analysis 22
3.6 Market Forecasts
22
CHAPTER 4 Generics in Europe 22
4.1 Market Overview 22
4.2
Market Value 22
4.3 Market Segmentation I 22
4.4 Market Segmentation
II 22
4.5 Five Forces Analysis 22
Market Forecasts 22
Market
Forecasts 22
CHAPTER 5 Generics in Belgium 22
5.1 Market Overview
22
5.2 Market Value 22
5.3 Market Segmentation I 22
5.4 Market
Segmentation II 22
5.5 Five Forces Analysis 22
5.6 Market Forecasts
22
CHAPTER 6 Generics in Canada 22
6.1 Market Overview 22
6.2
Market Value 22
6.3 Market Segmentation I 22
6.4 Market Segmentation
II 22
6.5 Five Forces Analysis 22
CHAPTER 7 Generics in China 22
7.1 Market Overview 22
7.2 Market Value 22
7.3 Market Segmentation I
22
7.4 Market Segmentation II 22
7.5 Five Forces Analysis 22
7.6
Market Forecasts 22
CHAPTER 8 Generics in France 22
8.1 Market
Overview 22
8.2 Market Value 22
8.3 Market Segmentation I 22
8.4
Market Segmentation II 22
8.5 Five Forces Analysis 22
8.6 Market
Forecasts 22
CHAPTER 9 Generics in Germany 22
9.1 Market Overview
22
9.2 Market Value 22
9.3 Market Segmentation I 22
9.4 Market
Segmentation II 22
9.5 Five Forces Analysis 22
9.6 Market Forecasts
22
CHAPTER 10 Generics in Italy 22
10.1 Market Overview 22
10.2
Market Value 22
10.3 Market Segmentation I 22
10.4 Market Segmentation
II 22
10.5 Five Forces Analysis 22
CHAPTER 11 Generics in Japan 22
11.1 Market Overview 22
11.2 Market Value 22
11.3 Market Segmentation
I 22
11.4 Market Segmentation II 22
11.5 Five Forces Analysis 22
CHAPTER 12 Generics in the Netherlands 22
12.1 Market Overview 22
12.2
Market Value 22
12.3 Market Segmentation I 22
12.4 Market Segmentation
II 22
12.5 Five Forces Analysis 22
12.6 Market Forecasts 22
CHAPTER 13 Generics in Spain 22
13.1 Market Overview 22
13.2 Market
Value 22
13.3 Market Segmentation I 22
13.4 Market Segmentation II
22
13.5 Five Forces Analysis 22
13.6 Market Forecasts 22
CHAPTER
14 Generics in the United Kingdom 22
14.1 Market Overview 22
14.2
Market Value 22
14.3 Market Segmentation I 22
14.4 Market Segmentation
II 22
14.5 Five Forces Analysis 22
14.6 Market Forecasts 22
CHAPTER 15 Generics in the United States 22
15.1 Market Overview 22
15.2 Market Value 22
15.3 Market Segmentation I 22
15.4 Market
Segmentation II 22
15.5 Five Forces Analysis 22
CHAPTER 16 COMPANY
PROFILES 22
16.1 Leading Companies 22
CHAPTER 17 Appendix 22
17.1
Data Research Methodology 22
List of Tables
Table 1: Global
Generics Market Value: $ billion, 2003-2007 22
Table 2: Global Generics
Market Segmentation I: % Share, by Value, 2007 22
Table 3: Global Generics
Market Segmentation II: % Share, by Value, 2007 22
Table 4: Global
Generics Market Value Forecast: $ billion, 2007-2012 22
Table 5:
Asia-Pacific Generics Market Value: $ billion, 2003-2007 22
Table 6:
Asia-Pacific Generics Market Segmentation I: % Share, by Value, 2007 22
Table 7: Asia-Pacific Generics Market Segmentation II: % Share, by Value, 2007
22
Table 8: Asia-Pacific Generics Market Value Forecast: $ billion,
2007-2012 22
Table 9: Europe Generics Market Value: $ billion, 2003-2007
22
Table 10: Europe Generics Market Segmentation I: % Share, by Value,
2007 22
Table 11: Europe Generics Market Segmentation II: % Share, by
Value, 2007 22
Table 12: Europe Generics Market Value Forecast: $ billion,
2007-2012 22
Table 13: Belgium Generics Market Value: $ million, 2003-2007
22
Table 14: Belgium Generics Market Segmentation I: % Share, by Value,
2007 22
Table 15: Belgium Generics Market Segmentation II: % Share, by
Value, 2007 22
Table 16: Belgium Generics Market Value Forecast: $
million, 2007-2012 22
Table 17: Canada Generics Market Value: $ billion,
2003-2007 22
Table 18: Canada Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 19: Canada Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 20: Canada Generics Market Value Forecast: $
billion, 2007-2012 22
Table 21: China Generics Market Value: $ billion,
2003-2007 22
Table 22: China Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 23: China Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 24: China Generics Market Value Forecast: $
billion, 2007-2012 22
Table 25: France Generics Market Value: $ billion,
2003-2007 22
Table 26: France Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 27: France Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 28: France Generics Market Value Forecast: $
billion, 2007-2012 22
Table 29: Germany Generics Market Value: $ billion,
2003-2007 22
Table 30: Germany Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 31: Germany Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 32: Germany Generics Market Value Forecast: $
billion, 2007-2012 22
Table 33: Italy Generics Market Value: $ million,
2003-2007 22
Table 34: Italy Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 35: Italy Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 36: Italy Generics Market Value Forecast: $
million, 2007-2012 22
Table 37: Japan Generics Market Value: $ billion,
2003-2007 22
Table 38: Japan Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 39: Japan Generics Market Segmentation II: % Share,
by Value, 2007 22
Table 40: Japan Generics Market Value Forecast: $
billion, 2007-2012 22
Table 41: Netherlands Generics Market Value: $
billion, 2003-2007 22
Table 42: Netherlands Generics Market Segmentation
I: % Share, by Value, 2007 22
Table 43: Netherlands Generics Market
Segmentation II: % Share, by Value, 2007 22
Table 44: Netherlands Generics
Market Value Forecast: $ billion, 2007-2012 22
Table 45: Spain Generics
Market Value: $ billion, 2003-2007 22
Table 46: Spain Generics Market
Segmentation I: % Share, by Value, 2007 22
Table 47: Spain Generics Market
Segmentation II: % Share, by Value, 2007 22
Table 48: Spain Generics
Market Value Forecast: $ billion, 2007-2012 22
Table 49: United Kingdom
Generics Market Value: $ billion, 2003-2007 22
Table 50: United Kingdom
Generics Market Segmentation I: % Share, by Value, 2007 22
Table 51:
United Kingdom Generics Market Segmentation II: % Share, by Value, 2007 22
Table 52: United Kingdom Generics Market Value Forecast: $ billion, 2007-2012
22
Table 53: United States Generics Market Value: $ billion, 2003-2007
22
Table 54: United States Generics Market Segmentation I: % Share, by
Value, 2007 22
Table 55: United States Generics Market Segmentation II: %
Share, by Value, 2007 22
Table 56: United States Generics Market Value
Forecast: $ billion, 2007-2012 22
Table 57: Key Facts: Teva Pharmaceutical
Industries 22
Table 58: Key Financials: Teva Pharmaceutical Industries
22
Table 59: Key Facts: Sandoz GmbH 22
Table 60: Key Facts: Merck KGaA
22
Table 61: Key Financials: Merck KGaA 22
List of
Figures
Figure 1: Global Generics Market Value: $ billion, 2003-2007
22
Figure 2: Global Generics Market Segmentation I: % Share, by Value,
2007 22
Figure 3: Global Generics Market Segmentation II: % Share, by
Value, 2007 22
Figure 4: Forces Driving Competition in the Generics Market
in Global, 2007 22
Figure 5: Drivers of Buyer Power in the Generics Market
in Global, 2007 22
Figure 6: Drivers of Supplier Power in the Generics
Market in Global, 2007 22
Figure 7: Factors Influencing the Likelihood of
New Entrants in the Generics Market in Global, 2007 22
Figure 8: Factors
Influencing the Threat of Substitutes in the Generics Market in Global, 2007
22
Figure 9: Drivers of Degree of Rivalry in the Generics Market in
Global, 2007 22
Figure 10: Global Generics Market Value Forecast: $
billion, 2007-2012 22
Figure 11: Asia-Pacific Generics Market Value: $
billion, 2003-2007 22
Figure 12: Asia-Pacific Generics Market Segmentation
I: % Share, by Value, 2007 22
Figure 13: Asia-Pacific Generics Market
Segmentation II: % Share, by Value, 2007 22
Figure 14: Forces Driving
Competition in the Generics Market in Asia-Pacific, 2007 22
Figure 15:
Drivers of Buyer Power in the Generics Market in Asia-Pacific, 2007 22
Figure 16: Drivers of Supplier Power in the Generics Market in Asia-Pacific,
2007 22
Figure 17: Factors Influencing the Likelihood of New Entrants in
the Generics Market in Asia-Pacific, 2007 22
Figure 18: Factors
Influencing the Threat of Substitutes in the Generics Market in Asia-Pacific,
2007 22
Figure 19: Drivers of Degree of Rivalry in the Generics Market in
Asia-Pacific, 2007 22
Figure 20: Asia-Pacific Generics Market Value
Forecast: $ billion, 2007-2012 22
Figure 21: Europe Generics Market Value:
$ billion, 2003-2007 22
Figure 22: Europe Generics Market Segmentation I:
% Share, by Value, 2007 22
Figure 23: Europe Generics Market Segmentation
II: % Share, by Value, 2007 22
Figure 24: Forces Driving Competition in
the Generics Market in Europe, 2007 22
Figure 25: Drivers of Buyer Power
in the Generics Market in Europe, 2007 22
Figure 26: Drivers of Supplier
Power in the Generics Market in Europe, 2007 22
Figure 27: Factors
Influencing the Likelihood of New Entrants in the Generics Market in Europe,
2007 22
Figure 28: Factors Influencing the Threat of Substitutes in the
Generics Market in Europe, 2007 22
Figure 29: Drivers of Degree of
Rivalry in the Generics Market in Europe, 2007 22
Figure 30: Europe
Generics Market Value Forecast: $ billion, 2007-2012 22
Figure 31: Belgium
Generics Market Value: $ million, 2003-2007 22
Figure 32: Belgium Generics
Market Segmentation I: % Share, by Value, 2007 22
Figure 33: Belgium
Generics Market Segmentation II: % Share, by Value, 2007 22
Figure 34:
Forces Driving Competition in the Generics Market in Belgium, 2007 22
Figure 35: Drivers of Buyer Power in the Generics Market in Belgium, 2007
22
Figure 36: Drivers of Supplier Power in the Generics Market in Belgium,
2007 22
Figure 37: Factors Influencing the Likelihood of New Entrants in
the Generics Market in Belgium, 2007 22
Figure 38: Factors Influencing the
Threat of Substitutes in the Generics Market in Belgium, 2007 22
Figure
39: Drivers of Degree of Rivalry in the Generics Market in Belgium, 2007
22
Figure 40: Belgium Generics Market Value Forecast: $ million, 2007-2012
22
Figure 41: Canada Generics Market Value: $ billion, 2003-2007 22
Figure 42: Canada Generics Market Segmentation I: % Share, by Value, 2007
22
Figure 43: Canada Generics Market Segmentation II: % Share, by Value,
2007 22
Figure 44: Forces Driving Competition in the Generics Market in
Canada, 2007 22
Figure 45: Drivers of Buyer Power in the Generics Market
in Canada, 2007 22
Figure 46: Drivers of Supplier Power in the Generics
Market in Canada, 2007 22
Figure 47: Factors Influencing the Likelihood of
New Entrants in the Generics Market in Canada, 2007 22
Figure 48: Factors
Influencing the Threat of Substitutes in the Generics Market in Canada, 2007
22
Figure 49: Drivers of Degree of Rivalry in the Generics Market in
Canada, 2007 22
Figure 50: Canada Generics Market Value Forecast: $
billion, 2007-2012 22
Figure 51: China Generics Market Value: $ billion,
2003-2007 22
Figure 52: China Generics Market Segmentation I: % Share, by
Value, 2007 22
Figure 53: China Generics Market Segmentation II: % Share,
by Value, 2007 22
Figure 54: Forces Driving Competition in the Generics
Market in China, 2007 22
Figure 55: Drivers of Buyer Power in the Generics
Market in China, 2007 22
Figure 56: Drivers of Supplier Power in the
Generics Market in China, 2007 22
Figure 57: Factors Influencing the
Likelihood of New Entrants in the Generics Market in China, 2007 22
Figure
58: Factors Influencing the Threat of Substitutes in the Generics Market in
China, 2007 22
Figure 59: Drivers of Degree of Rivalry in the Generics
Market in China, 2007 22
Figure 60: China Generics Market Value Forecast:
$ billion, 2007-2012 22
Figure 61: France Generics Market Value: $
billion, 2003-2007 22
Figure 62: France Generics Market Segmentation I: %
Share, by Value, 2007 22
Figure 63: France Generics Market Segmentation
II: % Share, by Value, 2007 22
Figure 64: Forces Driving Competition in
the Generics Market in France, 2007 22
Figure 65: Drivers of Buyer Power
in the Generics Market in France, 2007 22
Figure 66: Drivers of Supplier
Power in the Generics Market in France, 2007 22
Figure 67: Factors
Influencing the Likelihood of New Entrants in the Generics Market in France,
2007 22
Figure 68: Factors Influencing the Threat of Substitutes in the
Generics Market in France, 2007 22
Figure 69: Drivers of Degree of
Rivalry in the Generics Market in France, 2007 22
Figure 70: France
Generics Market Value Forecast: $ billion, 2007-2012 22
Figure 71: Germany
Generics Market Value: $ billion, 2003-2007 22
Figure 72: Germany Generics
Market Segmentation I: % Share, by Value, 2007 22
Figure 73: Germany
Generics Market Segmentation II: % Share, by Value, 2007 22
Figure 74:
Forces Driving Competition in the the Generics Market in Germany, 2007 22
Figure 75: Drivers of Buyer Power in the the Generics Market in Germany, 2007
22
Figure 76: Drivers of Supplier Power in the the Generics Market in
Germany, 2007 22
Figure 77: Factors Influencing the Likelihood of New
Entrants in the the Generics Market in Germany, 2007 22
Figure 78: Factors
Influencing the Threat of Substitutes in the the Generics Market in Germany,
2007 22
Figure 79: Drivers of Degree of Rivalry in the Generics Market in
Germany, 2007 22
Figure 80: Germany Generics Market Value Forecast: $
billion, 2007-2012 22
Figure 81: Italy Generics Market Value: $ million,
2003-2007 22
Figure 82: Italy Generics Market Segmentation I: % Share, by
Value, 2007 22
Figure 83: Italy Generics Market Segmentation II: % Share,
by Value, 2007 22
Figure 84: Forces Driving Competition in the Generics
Market in Italy, 2007 22
Figure 85: Drivers of Buyer Power in the Generics
Market in Italy, 2007 22
Figure 86: Drivers of Supplier Power in the
Generics Market in Italy, 2007 22
Figure 87: Factors Influencing the
Likelihood of New Entrants in the Generics Market in Italy, 2007 22
Figure
88: Factors Influencing the Threat of Substitutes in the Generics Market in
Italy, 2007 22
Figure 89: Drivers of Degree of Rivalry in the Generics
Market in Italy, 2007 22
Figure 90: Italy Generics Market Value Forecast:
$ million, 2007-2012 22
Figure 91: Japan Generics Market Value: $ billion,
2003-2007 22
Figure 92: Japan Generics Market Segmentation I: % Share, by
Value, 2007 22
Figure 93: Japan Generics Market Segmentation II: % Share,
by Value, 2007 22
Figure 94: Forces Driving Competition in the Generics
Market in Japan, 2007 22
Figure 95: Drivers of Buyer Power in the Generics
Market in Japan, 2007 22
Figure 96: Drivers of Supplier Power in the
Generics Market in Japan, 2007 22
Figure 97: Factors Influencing the
Likelihood of New Entrants in the Generics Market in Japan, 2007 22
Figure
98: Factors Influencing the Threat of Substitutes in the Generics Market in
Japan, 2007 22
Figure 99: Drivers of Degree of Rivalry in the Generics
Market in Japan, 2007 22
Figure 100: Japan Generics Market Value Forecast:
$ billion, 2007-2012 22
Figure 101: Netherlands Generics Market Value: $
billion, 2003-2007 22
Figure 102: Netherlands Generics Market Segmentation
I: % Share, by Value, 2007 22
Figure 103: Netherlands Generics Market
Segmentation II: % Share, by Value, 2007 22
Figure 104: Forces Driving
Competition in the Generics Market in the Netherlands, 2007 22
Figure
105: Drivers of Buyer Power in the Generics Market in the Netherlands, 2007
22
Figure 106: Drivers of Supplier Power in the Generics Market in the
Netherlands, 2007 22
Figure 107: Factors Influencing the Likelihood of New
Entrants in the Generics Market in the Netherlands, 2007 22
Figure 108:
Factors Influencing the Threat of Substitutes in the Generics Market in the
Netherlands, 2007 22
Figure 109: Drivers of Degree of Rivalry in the
Generics Market in the Netherlands, 2007 22
Figure 110: Netherlands
Generics Market Value Forecast: $ billion, 2007-2012 22
Figure 111: Spain
Generics Market Value: $ billion, 2003-2007 22
Figure 112: Spain Generics
Market Segmentation I: % Share, by Value, 2007 22
Figure 113: Spain
Generics Market Segmentation II: % Share, by Value, 2007 22
Figure 114:
Forces Driving Competition in the Generics Market in Spain, 2007 22
Figure
115: Drivers of Buyer Power in the Generics Market in Spain, 2007 22
Figure 116: Drivers of Supplier Power in the Generics Market in Spain, 2007
22
Figure 117: Factors Influencing the Likelihood of New Entrants in the
Generics Market in Spain, 2007 22
Figure 118: Factors Influencing the
Threat of Substitutes in the Generics Market in Spain, 2007 22
Figure
119: Drivers of Degree of Rivalry in the Generics Market in Spain, 2007 22
Figure 120: Spain Generics Market Value Forecast: $ billion, 2007-2012 22
Figure 121: United Kingdom Generics Market Value: $ billion, 2003-2007 22
Figure 122: United Kingdom Generics Market Segmentation I: % Share, by Value,
2007 22
Figure 123: United Kingdom Generics Market Segmentation II: %
Share, by Value, 2007 22
Figure 124: Forces Driving Competition in the
Generics Market in the UK, 2007 22
Figure 125: Drivers of Buyer Power in
the Generics Market in the UK, 2007 22
Figure 126: Drivers of Supplier
Power in the Generics Market in the UK, 2007 22
Figure 127: Factors
Influencing the Likelihood of New Entrants in the Generics Market in the UK,
2007 22
Figure 128: Factors Influencing the Threat of Substitutes in the
Generics Market in the UK, 2007 22
Figure 129: Drivers of Degree of
Rivalry in the Generics Market in the UK, 2007 22
Figure 130: United
Kingdom Generics Market Value Forecast: $ billion, 2007-2012 22
Figure
131: United States Generics Market Value: $ billion, 2003-2007 22
Figure
132: United States Generics Market Segmentation I: % Share, by Value, 2007
22
Figure 133: United States Generics Market Segmentation II: % Share, by
Value, 2007 22
Figure 134: Forces Driving Competition in the Generics
Market in the United States, 2007 22
Figure 135: Drivers of Buyer Power
in the Generics Market in the United States, 2007 22
Figure 136: Drivers
of Supplier Power in the Generics Market in the United States, 2007 22
Figure 137: Factors Influencing the Likelihood of New Entrants in the Generics
Market in the United States, 2007 22
Figure 138: Factors Influencing the
Threat of Substitutes in the Generics Market in the United States, 2007 22
Figure 139: Drivers of Degree of Rivalry in the Generics Market in the United
States, 2007 22
Figure 140: United States Generics Market Value
Forecast: $ billion, 2007-2012 22
Figure 141: Revenues & Profitability:
Teva Pharmaceutical Industries 22
Figure 142: Revenues & Profitability:
Merck KGaA 22
|
相關報告
|
